Therapeutic area influences drug development costs

CNS and anti-infective treatments are the most expensive to develop. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution

RELEVANT ARTICLES Open Access articles citing this article. * EDITORIAL: PRECLINICAL DATA REPRODUCIBILITY FOR R&D - THE CHALLENGE FOR NEUROSCIENCE * Thomas Steckler _SpringerPlus_ Open

Access 13 January 2015 ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more

Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS:

* Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support Authors * Simon Frantz View author publications You can also search for this author inPubMed 

Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Frantz, S. Therapeutic area influences drug development costs. _Nat Rev Drug Discov_ 3,

466 (2004). https://doi.org/10.1038/nrd1436 Download citation * Issue Date: 01 June 2004 * DOI: https://doi.org/10.1038/nrd1436 SHARE THIS ARTICLE Anyone you share the following link with

will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt

content-sharing initiative